FDA reviewed 127 seizure reports, found no direct evidence linking them to vaping
On April 3, the U.S. Food and Drug Administration (FDA) issued a statement saying that e-cigarettes pose a possible seizure risk, which caused consumers to fear e-cigarettes. After the statement was released, shares of major tobacco companies such as Altr
On April 3, the U.S. Food and Drug Administration (FDA) released a statement indicating that e-cigarettes may pose a risk of triggering seizures, leading to consumer fear regarding vaping.
Following the statement, shares of well-known tobacco companies such as Altria Group and British American Tobacco plummeted. Altria Group fell 4.78% on Wednesday; British American Tobacco dropped 2.29%.
On August 7, the FDA announced that it is investigating 127 cases of individuals who experienced seizures after using e-cigarettes, but there is currently no direct evidence linking e-cigarettes to seizures.
Investigation of 127 related cases
In April, the FDA announced it had received 35 reports of seizure cases related to e-cigarette use, particularly among young users, spanning from 2010 to 2019. Due to the limited sample size, it could not be determined whether e-cigarettes caused the seizures, prompting the FDA to announce an investigation into the matter.
To date, the FDA has received approximately 92 new reports of seizures following e-cigarette use, including cases involving children and adolescents.
No direct evidence linking e-cigarettes
The FDA stated that the evidence analyzed so far has not established a clear pattern or cause for these cases. Other reports also "do not indicate an increased frequency or incidence of seizures among e-cigarette users."
The reported cases occurred between 2010 and 2019, and in addition to seizures, some individuals reported fainting or tremors.
FDA Commissioner Ned Sharpless stated, "We still do not have enough information to determine whether e-cigarettes caused these reported events," but urged the public to continue reporting cases to the FDA online.
"We greatly appreciate the public's response to our initial report, and we strongly encourage the public to submit new reports or follow-up reports as detailed as possible."
Following the statement, shares of well-known tobacco companies such as Altria Group and British American Tobacco plummeted. Altria Group fell 4.78% on Wednesday; British American Tobacco dropped 2.29%.
On August 7, the FDA announced that it is investigating 127 cases of individuals who experienced seizures after using e-cigarettes, but there is currently no direct evidence linking e-cigarettes to seizures.
Investigation of 127 related cases
In April, the FDA announced it had received 35 reports of seizure cases related to e-cigarette use, particularly among young users, spanning from 2010 to 2019. Due to the limited sample size, it could not be determined whether e-cigarettes caused the seizures, prompting the FDA to announce an investigation into the matter.
To date, the FDA has received approximately 92 new reports of seizures following e-cigarette use, including cases involving children and adolescents.
No direct evidence linking e-cigarettes
The FDA stated that the evidence analyzed so far has not established a clear pattern or cause for these cases. Other reports also "do not indicate an increased frequency or incidence of seizures among e-cigarette users."
The reported cases occurred between 2010 and 2019, and in addition to seizures, some individuals reported fainting or tremors.
FDA Commissioner Ned Sharpless stated, "We still do not have enough information to determine whether e-cigarettes caused these reported events," but urged the public to continue reporting cases to the FDA online.
"We greatly appreciate the public's response to our initial report, and we strongly encourage the public to submit new reports or follow-up reports as detailed as possible."
